# A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

> **NCT03563183** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26976 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **OTHER:** Encoding of data collected in Zoster 006 and Zoster 022 studies

## Key facts

- **NCT ID:** NCT03563183
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 26976 (ACTUAL)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563183, "A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03563183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*